Last reviewed · How we verify

NCT03795129

Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication

Status unknown NA Last updated 7 January 2019
What this trial tests

NA trial testing SleepLife Application w/FitBit in Insomnia in 200 participants. Status unknown.

Timeline
10 June 2018
Primary endpoint
31 December 2018
28 February 2019

Quick facts

Lead sponsorRegenstrief Institute, Inc.
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment200
Start date10 June 2018
Primary completion31 December 2018
Estimated completion28 February 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Regenstrief Institute, Inc.

Who can join

18 and older, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep related disorders are common in primary care practice. Sleep wear related data has not been utilized to improve sleep related communication between patients and providers. The study team is conducting a randomized study to improve physical-patient communication regarding sleep through a novel intervention based upon sleep wear and the Sleeplife® app.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03795129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing